SCHEMBL19909118

SCHEMBL19909118

Cc1ccccc1-c1ccc2c(c1)c1ccccc1n2-c1cc(C#N)cc(-n2c3ccccc3c3cc(-c4ccccc4C)ccc32)c1-c1cc(-c2ccccc2)nc(-c2ccccc2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.36
ADORA1 P30542 2/20 0.36
KDM4E B2RXH2 2/20 0.36
HPGD P15428 1/20 0.36
PPARG P37231 1/20 0.36
NCOA2 Q15596 1/20 0.36
NCOA1 Q15788 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
PTGER4 P35408 1/20 0.35
MYC P01106 1/20 0.35
SQOR Q9Y6N5 3/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ENPP3 O14638 1/20 0.34
ENPP1 P22413 1/20 0.34
ALDH1A1 P00352 2/20 0.33
ABCB1 P08183 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
AR P10275 1/20 0.33
NPY5R Q15761 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19913280 0.97 ADORA2A (0.38) ADORA2AADORA1KDM4EHPGDPPARG
SCHEMBL22563445 0.92 PTGER4 (0.37) ADORA2AADORA1KDM4EHPGDPPARG
SCHEMBL19913333 0.92 MYC (0.38) ADORA2AADORA1KDM4EHPGDPPARG
SCHEMBL19909172 0.92 KDM4E (0.39) ADORA2AADORA1KDM4EHPGDPPARG
SCHEMBL19909395 0.89 KDM4E (0.37) ADORA2AADORA1KDM4EHPGDPPARG
SCHEMBL19919474 0.89 GABRG2 (0.41) KDM4EHPGDMYCALDH1A1ABCB1
SCHEMBL23487780 0.89 L3MBTL1 (0.36) ADORA2AADORA1KDM4EHPGDPPARG
SCHEMBL19909175 0.89 MYC (0.42) ADORA2AADORA1KDM4EHPGDPPARG
SCHEMBL21414116 0.89 AR (0.38) KDM4EHPGDPTGER4ALDH1A1AR
SCHEMBL19909415 0.88 KDM4E (0.41) ADORA2AADORA1KDM4EHPGDPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287451-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 ADORA2A 4758/4885ADORA1 4641/4885KDM4E 3845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.